Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Study of EOS789 in Healthy Male Volunteers
jRCT2080222940Phase 1
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in cardiac morbidity comparing EOS789 with Placebo (2 arms).
02
Drugs
EOS789
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on jRCT2080222940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222940.